Literature DB >> 7591068

Molecular characterization and adhesive properties of CF29K, an adhesin of Klebsiella pneumoniae strains involved in nosocomial infections.

P Di Martino1, Y Bertin, J P Girardeau, V Livrelli, B Joly, A Darfeuille-Michaud.   

Abstract

We previously described a CS31A-related protein, CF29K, expressed by Klebsiella pneumoniae strains involved in nosocomial infections. In this study, we cloned and sequenced cf29A, the structural gene of the CF29K protein, and showed that CF29K is an antigenic subtype of CS31A. The CF29K protein was found to be identical to the CS31A-L protein on the basis of biochemical and immunological properties. In contrast, the CS31A-H protein presented a different apparent molecular mass during sodium dodecyl sulfate-polyacrylamide gel electrophoresis, a different limited degradation pattern with endopeptidase V8, and a specific conformational epitope. We cloned and sequenced the CS31A-L structural gene and confirmed that CF29K and CS31A-L are identical, but their major subunits differ from ClpG (the CS31A-H subtype major subunit) by one amino acid at position 89 of the mature protein, which is a lysine in CF29K instead of the asparagine in ClpG. Site-directed mutagenesis experiments demonstrated that the biochemical and immunological differences between CS31A-H and CF29K or CS31A-L were dependent only on the amino acid at position 89 of the mature protein. To study the adhesive properties of CS31A-H and CF29K in the same Escherichia coli reference strain, we performed transcomplementation experiments with the cloned CS31A major-subunit structural genes or cloned cf29A gene and the clp accessory genes of the CS31A operon. We showed that CS31A-L, CF29K, and CS31A-H were involved in adhesion to Caco-2 and Int-407 cells but not to HEp-2 cells. Nevertheless, K. pneumoniae strains and corresponding E. coli transconjugants producing CF29K adhered to cultured Caco-2, Int-407, and HEp-2 cells, indicating the expression of another R-plasmid-encoded adhesin that mediated adhesion to HEp-2 cells. The carbohydrate part of the eucaryotic receptor of CF29K and CS31A-H adhesins was investigated by adhesion inhibition experiments with Int-407 cells. Although CS31A and CF29K belong to the K88 adhesin family, the receptor does not contain N-acetyl-D-galactosamine residues but contains N-acetylneuraminic acid and N-acetyl-D-glucosamine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591068      PMCID: PMC173617          DOI: 10.1128/iai.63.11.4336-4344.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology.

Authors:  B T McGuinness; P R Lambden; J E Heckels
Journal:  Mol Microbiol       Date:  1993-02       Impact factor: 3.501

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Nosocomial klebsiella infections: intestinal colonization as a reservoir.

Authors:  R Selden; S Lee; W L Wang; J V Bennett; T C Eickhoff
Journal:  Ann Intern Med       Date:  1971-05       Impact factor: 25.391

4.  An attempt to identify the intestinal receptor for the K88 adhesin by means of a haemagglutination inhibition test using glycoproteins and fractions from sow colostrum.

Authors:  R A Gibbons; G W Jones; R Sellwood
Journal:  J Gen Microbiol       Date:  1975-02

5.  Evidence for pili-mediated adherence of Klebsiella pneumoniae to rat bladder epithelial cells in vitro.

Authors:  R C Fader; A E Avots-Avotins; C P Davis
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

Review 6.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.

Authors:  J Fogh; J M Fogh; T Orfeo
Journal:  J Natl Cancer Inst       Date:  1977-07       Impact factor: 13.506

7.  Clonal relationships among bovine pathogenic Escherichia coli producing surface antigen CS31A.

Authors:  M Contrepois; Y Bertin; J P Girardeau; B Picard; P Goullet
Journal:  FEMS Microbiol Lett       Date:  1993-01-15       Impact factor: 2.742

8.  Aggregative adherence of Klebsiella pneumoniae to human intestine-407 cells.

Authors:  S Favre-Bonte; A Darfeuille-Michaud; C Forestier
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Permissible peptide insertions surrounding the signal peptide-mature protein junction of the ClpG prepilin: CS31A fimbriae of Escherichia coli as carriers of foreign sequences.

Authors:  M Der Vartanian; M C Méchin; B Jaffeux; Y Bertin; I Félix; B Gaillard-Martinie
Journal:  Gene       Date:  1994-10-11       Impact factor: 3.688

View more
  29 in total

1.  Identification of a Klebsiella pneumoniae strain associated with nosocomial urinary tract infection.

Authors:  K S Kil; R O Darouiche; R A Hull; M D Mansouri; D M Musher
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Virulence factors and TEM-type β-lactamases produced by two isolates of an epidemic Klebsiella pneumoniae strain.

Authors:  Frédéric Robin; Claire Hennequin; Marek Gniadkowski; Racha Beyrouthy; Joanna Empel; Lucie Gibold; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

3.  Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development.

Authors:  Adam W Jenney; Abigail Clements; Jacinta L Farn; Odilia L Wijburg; Andrew McGlinchey; Denis W Spelman; Tyrone L Pitt; Mary E Kaufmann; Lisa Liolios; Margaret B Moloney; Steven L Wesselingh; Richard A Strugnell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  The central variable V2 region of the CS31A major subunit is involved in the receptor-binding domain.

Authors:  P Di Martino; J P Girardeau; M Der Vartanian; B Joly; A Darfeuille-Michaud
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Professor Arlette Darfeuille-Michaud: the discovery of adherent-invasive Escherichia coli.

Authors:  Ye Yang; Christian Jobin
Journal:  J Crohns Colitis       Date:  2015-03-10       Impact factor: 9.071

6.  Characterization of a DHA-1-producing Klebsiella pneumoniae strain involved in an outbreak and role of the AmpR regulator in virulence.

Authors:  Claire Hennequin; Frédéric Robin; Nadège Cabrolier; Richard Bonnet; Christiane Forestier
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

7.  Epidemiological study of pap genes among diarrheagenic or septicemic Escherichia coli strains producing CS31A and F17 adhesins and characterization of Pap(31A) fimbriae.

Authors:  Y Bertin; J P Girardeau; A Darfeuille-Michaud; C Martin
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

8.  Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratia clinical isolates involved in nosocomial infections.

Authors:  V Livrelli; C De Champs; P Di Martino; A Darfeuille-Michaud; C Forestier; B Joly
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

9.  Sialic acid involved in hypermucoviscosity phenotype of Klebsiella pneumoniae and associated with resistance to neutrophil phagocytosis.

Authors:  Chen-Hsiang Lee; Chia-Chi Chang; Jien-Wei Liu; Rong-Fu Chen; Kuender D Yang
Journal:  Virulence       Date:  2014-08-05       Impact factor: 5.882

10.  Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization.

Authors:  Sylvain Brisse; Cindy Fevre; Virginie Passet; Sylvie Issenhuth-Jeanjean; Régis Tournebize; Laure Diancourt; Patrick Grimont
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.